The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC
Clinical trial NCT04664829 · COMPLETED
Trial details
- NCT number
- NCT04664829
- Sponsor
- National Cancer Centre, Singapore
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2025-08-04
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.